Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sevgi B Rodan

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Bone and Mineral Metabolism|October 31, 2007
Involvement of alpha(v)beta3 integrins in osteoclast functionIchiro Nakamura, Le T Duong, Sevgi B Rodan, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitorsRobert M Rydzewski, Clifford Bryant, Renata Oballa, et al.
Journal of Medicinal Chemistry|December 13, 2002
Binding model for nonpeptide antagonists of alpha(v)beta(3) integrinBradley P Feuston, J Chris Culberson, Mark E Duggan, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitorsJoël Robichaud, Christopher Bayly, Renata Oballa, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.
Journal of Medicinal Chemistry|August 9, 2003
A novel class of nonpeptidic biaryl inhibitors of human cathepsin KJoël Robichaud, Renata Oballa, Peppi Prasit, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivativesJiabing Wang, Michael J Breslin, Paul J Coleman, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraintJames J Perkins, L T Duong, Carmen Fernandez-Metzler, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Non-peptide alphavbeta3 antagonists. Part 6: design and synthesis of alphavbeta3 antagonists containing a pyridone or pyrazinone central scaffoldMichael J Breslin, Mark E Duggan, Wasyl Halczenko, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Bone and Mineral Metabolism|October 31, 2007
Involvement of alpha(v)beta3 integrins in osteoclast functionIchiro Nakamura, Le T Duong, Sevgi B Rodan, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitorsRobert M Rydzewski, Clifford Bryant, Renata Oballa, et al.
Journal of Medicinal Chemistry|December 13, 2002
Binding model for nonpeptide antagonists of alpha(v)beta(3) integrinBradley P Feuston, J Chris Culberson, Mark E Duggan, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitorsJoël Robichaud, Christopher Bayly, Renata Oballa, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.
Journal of Medicinal Chemistry|August 9, 2003
A novel class of nonpeptidic biaryl inhibitors of human cathepsin KJoël Robichaud, Renata Oballa, Peppi Prasit, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivativesJiabing Wang, Michael J Breslin, Paul J Coleman, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraintJames J Perkins, L T Duong, Carmen Fernandez-Metzler, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Non-peptide alphavbeta3 antagonists. Part 6: design and synthesis of alphavbeta3 antagonists containing a pyridone or pyrazinone central scaffoldMichael J Breslin, Mark E Duggan, Wasyl Halczenko, et al.
Pageof 3